We recently updated our soy research page with a 2019 dose-response meta-analysis of 23 prospective studies. It included a total of 330,826 participants and found that both soy protein and soy isoflavones had a positive impact on breast cancer mortality (1). A 10 mg/day increase in soy isoflavone intake was associated with a 9% decreased risk of breast cancer mortality, and a 5 g/day increase in soy protein intake was associated with a 12% reduction in breast cancer death (1).
You may also like
by Jack Norris, RD We have extensively updated our page on Iodine. In researching issues surrounding the recent EPIC-Oxford bone fracture study […]
by Jack Norris, RD, LD We’ve updated our Iodine article with a new study on the iodine content of the breastmilk of […]
New meta-analysis finds little to no effect of increasing omega-3s.
The absorption section of our Vitamin A article has been updated with information addressing a genetic predisposition for being a “low responder” […]